Charles E. Cox

9.1k total citations · 1 hit paper
116 papers, 6.7k citations indexed

About

Charles E. Cox is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Charles E. Cox has authored 116 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Cancer Research, 61 papers in Pathology and Forensic Medicine and 46 papers in Oncology. Recurrent topics in Charles E. Cox's work include Breast Cancer Treatment Studies (75 papers), Breast Lesions and Carcinomas (59 papers) and Breast Implant and Reconstruction (32 papers). Charles E. Cox is often cited by papers focused on Breast Cancer Treatment Studies (75 papers), Breast Lesions and Carcinomas (59 papers) and Breast Implant and Reconstruction (32 papers). Charles E. Cox collaborates with scholars based in United States, Switzerland and India. Charles E. Cox's co-authors include Douglas S. Reintgen, Alan Cantor, Elisabeth Dupont, Ni Ni Ku, Claudia G. Berman, Christopher Salud, Eric Peltz, Cecile A. Lengacher, Kevin E. Kip and Keoni Nguyen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Applied Psychology and Cancer.

In The Last Decade

Charles E. Cox

113 papers receiving 6.5k citations

Hit Papers

Constitutive activation o... 2001 2026 2009 2017 2001 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Charles E. Cox 3.3k 2.7k 2.6k 2.0k 662 116 6.7k
Christina Davies 3.9k 1.2× 2.5k 0.9× 1.5k 0.6× 1.1k 0.6× 629 1.0× 53 6.9k
Edoardo Botteri 2.3k 0.7× 3.6k 1.3× 2.1k 0.8× 1.9k 1.0× 882 1.3× 181 8.2k
William B. Farrar 1.6k 0.5× 2.6k 0.9× 792 0.3× 1.3k 0.7× 490 0.7× 89 6.9k
Anees B. Chagpar 2.8k 0.8× 2.3k 0.8× 1.6k 0.6× 1.3k 0.6× 390 0.6× 223 5.2k
Theo Wobbes 1.2k 0.4× 1.7k 0.6× 1.1k 0.4× 1.3k 0.7× 687 1.0× 132 5.1k
Ian S. Fentiman 4.3k 1.3× 4.2k 1.5× 3.2k 1.2× 1.8k 0.9× 908 1.4× 204 9.6k
Claudio Luchini 1.1k 0.3× 2.8k 1.0× 758 0.3× 1.7k 0.9× 968 1.5× 206 7.3k
R.D. Rubens 2.1k 0.6× 3.7k 1.3× 818 0.3× 1.0k 0.5× 1.1k 1.6× 172 8.1k
Meena S. Moran 3.0k 0.9× 2.0k 0.7× 1.7k 0.6× 1.3k 0.6× 716 1.1× 147 5.2k
Jeffrey J. Kirshner 1.2k 0.4× 2.2k 0.8× 700 0.3× 1.0k 0.5× 399 0.6× 89 5.0k

Countries citing papers authored by Charles E. Cox

Since Specialization
Citations

This map shows the geographic impact of Charles E. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Cox more than expected).

Fields of papers citing papers by Charles E. Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Cox. The network helps show where Charles E. Cox may publish in the future.

Co-authorship network of co-authors of Charles E. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Cox. A scholar is included among the top collaborators of Charles E. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Cox. Charles E. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sapino, Anna, Paul Roepman, Sabine C. Linn, et al.. (2014). MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue. Journal of Molecular Diagnostics. 16(2). 190–197. 78 indexed citations
3.
Jakub, James W., Richard J. Gray, Amy C. Degnim, et al.. (2009). Current status of radioactive seed for localization of non palpable breast lesions. The American Journal of Surgery. 199(4). 522–528. 119 indexed citations
4.
Cox, Charles E., Ben Furman, John V. Kiluk, et al.. (2008). Use of Reoperative Sentinel Lymph Node Biopsy in Breast Cancer Patients. Journal of the American College of Surgeons. 207(1). 57–61. 44 indexed citations
5.
Lamichhane, Nirmal, et al.. (2007). Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer.. PubMed. 9(1). 22–6. 5 indexed citations
6.
White, Laura, et al.. (2005). An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. The American Journal of Surgery. 190(4). 563–566. 104 indexed citations
7.
Jakub, James W., Mark Ebert, Alan Cantor, et al.. (2004). Breast Cancer in Patients with Prior Augmentation: Presentation, Stage, and Lymphatic Mapping. Plastic & Reconstructive Surgery. 114(7). 1737–1742. 44 indexed citations
8.
Cox, Charles E., Ben Furman, Mark Ebert, et al.. (2003). Radioactive Seed Localization Breast Biopsy and Lumpectomy: Can Specimen Radiographs Be Eliminated?. Annals of Surgical Oncology. 10(9). 1039–1047. 49 indexed citations
9.
Lengacher, Cecile A., et al.. (2003). Design and Testing of the Use of a Complementary and Alternative Therapies Survey in Women With Breast Cancer. Oncology nursing forum. 30(5). 811–821. 39 indexed citations
10.
Cox, Charles E., Mark Ebert, & James W. Jakub. (2002). Learning and credentialing in breast cancer sentinel lymph node biopsy. 5(1). 27–34.
11.
Kumar, Nagi B., Alan Cantor, Kathy Allen, Diane Riccardi, & Charles E. Cox. (2002). The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer. 94(4). 1166–1174. 92 indexed citations
12.
Jakub, James W., Nils M. Diaz, Mark Ebert, et al.. (2002). Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. The American Journal of Surgery. 184(4). 302–306. 42 indexed citations
13.
Miguel, Rafael, Alan R. Shons, Mark Ebert, et al.. (2001). The Effect of Sentinel Node Selective Axillary Lymphadenectomy on the Incidence of Postmastectomy Pain Syndrome. Cancer Control. 8(5). 427–430. 41 indexed citations
14.
Cox, Charles E., Christopher Salud, Alan Cantor, et al.. (2001). Learning Curves for Breast Cancer Sentinel Lymph Node Mapping Based on Surgical Volume Analysis. Journal of the American College of Surgeons. 193(6). 593–600. 128 indexed citations
15.
Shons, Alan R. & Charles E. Cox. (2001). Breast Cancer: Advances in Surgical Management. Plastic & Reconstructive Surgery. 107(2). 541–549. 12 indexed citations
16.
Cox, Charles E., et al.. (2000). THE ROLE OF SELECTIVE SENTINEL LYMPH NODE DISSECTION IN BREAST CANCER. Surgical Clinics of North America. 80(6). 1759–1777. 39 indexed citations
17.
Kumar, Nagi B., Alan Cantor, Kathy Allen, & Charles E. Cox. (2000). Android obesity at diagnosis and breast carcinoma survival. Cancer. 88(12). 2751–2757. 59 indexed citations
18.
Pendas, Solange, Ni Ni Ku, Douglas S. Reintgen, et al.. (1999). Microstaging of Breast Cancer Patients Using Cytokeratin Staining of the Sentinel Lymph Node. Annals of Surgical Oncology. 6(1). 95–101. 72 indexed citations
19.
Cox, Charles E., et al.. (1999). The role of sentinel lymph node biopsy in breast cancer11No competing interests declared.. Journal of the American College of Surgeons. 189(2). 183–194. 173 indexed citations
20.
Schapira, David V., Nagi B. Kumar, Gary H. Lyman, & Charles E. Cox. (1991). Obesity and body fat distribution and breast cancer prognosis. Cancer. 67(2). 523–528. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026